ELISE GUIDRY: Open Payments
NPI 1174089635 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 28 payments from 11 companies in 2025. Trend: 2023 $20 · 2024 $274 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 8 | $241 |
| Axsome Therapeutics, Inc. | 6 | $112 |
| Indivior Inc. | 5 | $83 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Abbott Laboratories | 1 | $19 |
| Braeburn Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
Products named: FANAPT, Auvelity, SUBLOCADE, INGREZZA, CAPLYTA, REXULTI, Qelbree, FREESTYLE LIBRE.
Industry payments across LA — which companies pay providers there.
